Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Potential benefits of weight loss in coronary heart disease.

Ades PA, Savage PD.

Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):448-56. doi: 10.1016/j.pcad.2013.09.009. Epub 2013 Oct 9. Review.

PMID:
24438737
[PubMed - indexed for MEDLINE]
2.

Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Sanchez-Infantes D, White UA, Elks CM, Morrison RF, Gimble JM, Considine RV, Ferrante AW, Ravussin E, Stephens JM.

J Clin Endocrinol Metab. 2014 Feb;99(2):E217-25. doi: 10.1210/jc.2013-3555. Epub 2013 Dec 2.

PMID:
24297795
[PubMed - indexed for MEDLINE]
3.

Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats.

Maeda S, Yamagishi S, Matsui T, Nakashima S, Ojima A, Maeda S, Nishino Y, Ishibashi Y, Yoshida Y, Yamakawa R.

Ophthalmic Res. 2013;50(4):221-6. doi: 10.1159/000354116. Epub 2013 Sep 25.

PMID:
24081217
[PubMed - indexed for MEDLINE]
4.

Ectopic fat and cardiometabolic and vascular risk.

Lim S, Meigs JB.

Int J Cardiol. 2013 Nov 5;169(3):166-76. doi: 10.1016/j.ijcard.2013.08.077. Epub 2013 Sep 7. Review.

PMID:
24063931
[PubMed - indexed for MEDLINE]
5.

Extraglycemic effects of glp-1-based therapeutics: addressing metabolic and cardiovascular risks associated with type 2 diabetes.

Herzlinger S, Horton ES.

Diabetes Res Clin Pract. 2013 Apr;100(1):1-10. doi: 10.1016/j.diabres.2012.11.009. Epub 2013 Jan 14. Review.

PMID:
23332049
[PubMed - indexed for MEDLINE]
6.

Liver fat content is linked to inflammatory changes in subcutaneous adipose tissue in type 2 diabetes patients.

Jansen HJ, Vervoort GM, van der Graaf M, Stienstra R, Tack CJ.

Clin Endocrinol (Oxf). 2013 Nov;79(5):661-6. doi: 10.1111/cen.12105. Epub 2013 Apr 19.

PMID:
23167778
[PubMed - indexed for MEDLINE]
7.

PAI-1 and diabetes: a journey from the bench to the bedside.

Schneider DJ, Sobel BE.

Diabetes Care. 2012 Oct;35(10):1961-7. No abstract available.

PMID:
22996180
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.

Nam DH, Lee MH, Kim JE, Song HK, Kang YS, Lee JE, Kim HW, Cha JJ, Hyun YY, Kim SH, Han SY, Han KH, Han JY, Cha DR.

Endocrinology. 2012 Mar;153(3):1387-96. doi: 10.1210/en.2011-1423. Epub 2012 Jan 10.

PMID:
22234468
[PubMed - indexed for MEDLINE]
9.

Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review).

Jankun J, Al-Senaidy A, Skrzypczak-Jankun E.

Int J Mol Med. 2012 Jan;29(1):3-11. doi: 10.3892/ijmm.2011.810. Epub 2011 Oct 11. Review.

PMID:
21993838
[PubMed - indexed for MEDLINE]
10.

Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients.

Csongrádi É, Nagy B Jr, Fulop T, Varga Z, Karányi Z, Magyar MT, Oláh L, Papp M, Facskó A, Kappelmayer J, Paragh G, Káplár M.

Thromb Haemost. 2011 Oct;106(4):683-92. doi: 10.1160/TH11-01-0030. Epub 2011 Aug 25.

PMID:
21866298
[PubMed - indexed for MEDLINE]
11.

Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.

Belalcazar LM, Ballantyne CM, Lang W, Haffner SM, Rushing J, Schwenke DC, Pi-Sunyer FX, Tracy RP; Look Action for Health in Diabetes Research Group.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1689-95. doi: 10.1161/ATVBAHA.111.224386. Epub 2011 Apr 21.

PMID:
21512162
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Vascular biology of metabolic syndrome.

Vykoukal D, Davies MG.

J Vasc Surg. 2011 Sep;54(3):819-31. doi: 10.1016/j.jvs.2011.01.003. Epub 2011 Mar 24. Review.

PMID:
21439758
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.

Matsui T, Nishino Y, Takeuchi M, Yamagishi S.

Pharmacol Res. 2011 May;63(5):383-8. doi: 10.1016/j.phrs.2011.02.003. Epub 2011 Feb 12.

PMID:
21320599
[PubMed - indexed for MEDLINE]
14.

Body size phenotypes and inflammation in the Women's Health Initiative Observational Study.

Wildman RP, Kaplan R, Manson JE, Rajkovic A, Connelly SA, Mackey RH, Tinker LF, Curb JD, Eaton CB, Wassertheil-Smoller S.

Obesity (Silver Spring). 2011 Jul;19(7):1482-91. doi: 10.1038/oby.2010.332. Epub 2011 Jan 13.

PMID:
21233809
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide-1-based therapies.

Chilton R, Wyatt J, Nandish S, Oliveros R, Lujan M.

Am J Med. 2011 Jan;124(1 Suppl):S35-53. doi: 10.1016/j.amjmed.2010.11.004. Review.

PMID:
21194579
[PubMed - indexed for MEDLINE]
16.

Obesity, type 2 diabetes and risk of digestive cancer.

Hillon P, Guiu B, Vincent J, Petit JM.

Gastroenterol Clin Biol. 2010 Oct;34(10):529-33. doi: 10.1016/j.gcb.2010.07.021. Review.

PMID:
20864282
[PubMed - indexed for MEDLINE]
Free Article
17.

The metabolic syndrome - an ongoing story.

Duvnjak L, Duvnjak M.

J Physiol Pharmacol. 2009 Dec;60 Suppl 7:19-24. Review.

PMID:
20388942
[PubMed - indexed for MEDLINE]
Free Article
18.

Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.

Kishore P, Li W, Tonelli J, Lee DE, Koppaka S, Zhang K, Lin Y, Kehlenbrink S, Scherer PE, Hawkins M.

Sci Transl Med. 2010 Feb 24;2(20):20ra15. doi: 10.1126/scitranslmed.3000292.

PMID:
20371491
[PubMed - indexed for MEDLINE]
Free Article
19.

Adipose tissue macrophages: a piece of the PAI of metabolic syndrome.

Lumeng CN.

Sci Transl Med. 2010 Feb 24;2(20):20ps7. doi: 10.1126/scitranslmed.3000850.

PMID:
20371488
[PubMed - indexed for MEDLINE]
20.

PAI-1 antagonists: the promise and the peril.

Vaughan DE.

Trans Am Clin Climatol Assoc. 2011;122:312-25.

PMID:
21686234
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk